Novartis Reduces Outsourcing Through Parexel; CRO To Lay Off 400-500
Executive Summary
Novartis' cancellation of several outsourcing contracts with Parexel could result in a reduction of the contract research organization's workforce by 400-500 positions, Parexel said.